Market Cap 1.83B
Revenue (ttm) 184.42M
Net Income (ttm) -6.89M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3.74%
Debt to Equity Ratio 0.00
Volume 181,468
Avg Vol 553,168
Day's Range N/A - N/A
Shares Out 62.28M
Stochastic %K 1%
Beta 1.17
Analysts Strong Sell
Price Target $45.07

Company Profile

Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in Phase 1 clinical trials for the treatment of autosomal dominant optic atrophy; and Zorevunersen (STK-001), an investigational n...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 430 8200
Address:
45 Wiggins Avenue, Bedford, United States
urban979
urban979 May. 31 at 6:43 PM
$STOK Strong pharma partnerships validate platform”
0 · Reply
SuperGreenToday
SuperGreenToday May. 30 at 12:38 AM
$STOK Share Price: $30.89 Contract Selected: Nov 20, 2026 $30 Calls Buy Zone: $4.25 – $5.25 Target Zone: $7.20 – $8.80 Potential Upside: 60% ROI Time to Expiration: 174 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
NVDAMillionaire
NVDAMillionaire May. 20 at 9:38 PM
$STOK Outstanding article that hits the mark on STOK's current state. So if you want to refresh your STOK insights or learn about STOK from scratch, this is a must read. https://everyticker.com/quote/STOK/analysis/stoke-therapeutics-a-funded-binary-bet-on-orphan-drug-pricing-power-nasdaq-stok
0 · Reply
MarketBeat
MarketBeat May. 9 at 4:08 AM
Stoke Therapeutics Q1 Earnings Call Highlights $STOK https://www.marketbeat.com/instant-alerts/stoke-therapeutics-q1-earnings-call-highligh
0 · Reply
LadsAndGents
LadsAndGents May. 5 at 3:30 PM
$STOK please go to 24 former load back again
0 · Reply
Doozio
Doozio May. 4 at 2:33 PM
$XBI ACSM BODI n they wud say DRUG $STOK s will start gapping right on $CUE
0 · Reply
GorillaTrades
GorillaTrades Apr. 17 at 7:03 PM
Top 3 #momentum #stocks In The GorillaTrades #portfolio This Week: Stoke Therapeutics $STOK +6.6%, NVIDIA $NVDA +6.5%, and Celcuity $CELC +4.6%
0 · Reply
GorillaTrades
GorillaTrades Apr. 10 at 7:37 PM
Top 3 #momentum #stocks In The GorillaTrades #portfolio This Week: Stoke Therapeutics $STOK +6.7%, Celcuity $CELC +3.6%, and Cincinnati Financial $CINF +2.5%
0 · Reply
Doozio
Doozio Apr. 10 at 1:05 AM
$IWM $SMH $XBI how long until they go from fear to walking ENTA da weekend chasing $STTK s and $STOK s.
0 · Reply
NorthStarStats
NorthStarStats Apr. 8 at 8:39 PM
Output from a custom NorthStarStats momentum scanner highlighting stocks with strengthening price structure and momentum. Setups to watch and study — not trade recommendations. $FRT Score 100, $ANET Score 98, $ENTG Score 98, $STOK Score 98, $ASND Score 98
0 · Reply
Latest News on STOK
Stoke Therapeutics Transcript: AGM 2026

Jun 3, 2026, 9:00 AM EDT - 8 days ago

Stoke Therapeutics Transcript: AGM 2026


Stoke Therapeutics reports Q1 EPS (79c), consensus (84c)

2026-05-07T21:42:17.000Z - 4 weeks ago

Stoke Therapeutics reports Q1 EPS (79c), consensus (84c)


Stoke Therapeutics Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 weeks ago

Stoke Therapeutics Earnings Call Transcript: Q1 2026


Stoke Therapeutics Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 weeks ago

Stoke Therapeutics Earnings release: Q1 2026


Stoke Therapeutics Slides: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 weeks ago

Stoke Therapeutics Slides: Q1 2026


Stoke Therapeutics Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 weeks ago

Stoke Therapeutics Quarterly report: Q1 2026


Stoke Therapeutics Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 7 weeks ago

Stoke Therapeutics Proxy statement: Proxy filing


Stoke Therapeutics Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 7 weeks ago

Stoke Therapeutics Proxy statement: Proxy filing


Stoke Therapeutics files automatic mixed securities shelf

2026-03-18T20:11:56.000Z - 3 months ago

Stoke Therapeutics files automatic mixed securities shelf


Stoke Therapeutics Annual report: Q4 2025

Mar 16, 2026, 7:00 AM EDT - 3 months ago

Stoke Therapeutics Annual report: Q4 2025


Stoke Therapeutics initiated with a Buy at Guggenheim

2026-02-05T10:00:36.000Z - 4 months ago

Stoke Therapeutics initiated with a Buy at Guggenheim


Stoke Therapeutics Earnings Call Transcript: Q3 2025

Nov 4, 2025, 4:30 PM EST - 7 months ago

Stoke Therapeutics Earnings Call Transcript: Q3 2025


Stoke Therapeutics Quarterly report: Q3 2025

Nov 4, 2025, 4:30 PM EST - 7 months ago

Stoke Therapeutics Quarterly report: Q3 2025


Stoke Therapeutics Earnings release: Q3 2025

Nov 4, 2025, 4:30 PM EST - 7 months ago

Stoke Therapeutics Earnings release: Q3 2025


Stoke Therapeutics Slides: Q3 2025

Nov 4, 2025, 4:30 PM EST - 7 months ago

Stoke Therapeutics Slides: Q3 2025


Stoke Therapeutics reports Q3 EPS (65c), consensus (57c)

2025-11-04T21:06:06.000Z - 7 months ago

Stoke Therapeutics reports Q3 EPS (65c), consensus (57c)


Stoke Therapeutics Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 10 months ago

Stoke Therapeutics Earnings Call Transcript: Q2 2025


Stoke Therapeutics Quarterly report: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 10 months ago

Stoke Therapeutics Quarterly report: Q2 2025


Stoke Therapeutics Earnings release: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 10 months ago

Stoke Therapeutics Earnings release: Q2 2025


Stoke Therapeutics Slides: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 10 months ago

Stoke Therapeutics Slides: Q2 2025


Stoke Therapeutics Quarterly report: Q1 2025

May 13, 2025, 7:30 AM EDT - 1 year ago

Stoke Therapeutics Quarterly report: Q1 2025


Stoke Therapeutics Earnings release: Q1 2025

May 13, 2025, 7:30 AM EDT - 1 year ago

Stoke Therapeutics Earnings release: Q1 2025


Stoke Therapeutics Proxy statement: Proxy Filing

Apr 22, 2025, 8:00 AM EDT - 1 year ago

Stoke Therapeutics Proxy statement: Proxy Filing


Stoke Therapeutics Proxy statement: Proxy Filing

Apr 22, 2025, 8:00 AM EDT - 1 year ago

Stoke Therapeutics Proxy statement: Proxy Filing


Stoke Therapeutics Stock Slips as CEO Steps Down

Mar 18, 2025, 12:56 PM EDT - 1 year ago

Stoke Therapeutics Stock Slips as CEO Steps Down


Stoke Therapeutics Annual report: Q4 2024

Mar 18, 2025, 7:00 AM EDT - 1 year ago

Stoke Therapeutics Annual report: Q4 2024


Stoke Therapeutics Earnings release: Q4 2024

Mar 18, 2025, 7:00 AM EDT - 1 year ago

Stoke Therapeutics Earnings release: Q4 2024


Stoke Therapeutics Announces CEO Transition

Mar 18, 2025, 6:58 AM EDT - 1 year ago

Stoke Therapeutics Announces CEO Transition


Stoke Therapeutics Transcript: Status Update

Dec 9, 2024, 8:30 AM EST - 1 year ago

Stoke Therapeutics Transcript: Status Update


Stoke Therapeutics Slides: Status Update

Dec 9, 2024, 8:30 AM EST - 1 year ago

Stoke Therapeutics Slides: Status Update


Stoke Therapeutics Quarterly report: Q3 2024

Nov 5, 2024, 7:00 AM EST - 1 year ago

Stoke Therapeutics Quarterly report: Q3 2024


Stoke Therapeutics Earnings release: Q3 2024

Nov 5, 2024, 7:00 AM EST - 1 year ago

Stoke Therapeutics Earnings release: Q3 2024


urban979
urban979 May. 31 at 6:43 PM
$STOK Strong pharma partnerships validate platform”
0 · Reply
SuperGreenToday
SuperGreenToday May. 30 at 12:38 AM
$STOK Share Price: $30.89 Contract Selected: Nov 20, 2026 $30 Calls Buy Zone: $4.25 – $5.25 Target Zone: $7.20 – $8.80 Potential Upside: 60% ROI Time to Expiration: 174 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
NVDAMillionaire
NVDAMillionaire May. 20 at 9:38 PM
$STOK Outstanding article that hits the mark on STOK's current state. So if you want to refresh your STOK insights or learn about STOK from scratch, this is a must read. https://everyticker.com/quote/STOK/analysis/stoke-therapeutics-a-funded-binary-bet-on-orphan-drug-pricing-power-nasdaq-stok
0 · Reply
MarketBeat
MarketBeat May. 9 at 4:08 AM
Stoke Therapeutics Q1 Earnings Call Highlights $STOK https://www.marketbeat.com/instant-alerts/stoke-therapeutics-q1-earnings-call-highligh
0 · Reply
LadsAndGents
LadsAndGents May. 5 at 3:30 PM
$STOK please go to 24 former load back again
0 · Reply
Doozio
Doozio May. 4 at 2:33 PM
$XBI ACSM BODI n they wud say DRUG $STOK s will start gapping right on $CUE
0 · Reply
GorillaTrades
GorillaTrades Apr. 17 at 7:03 PM
Top 3 #momentum #stocks In The GorillaTrades #portfolio This Week: Stoke Therapeutics $STOK +6.6%, NVIDIA $NVDA +6.5%, and Celcuity $CELC +4.6%
0 · Reply
GorillaTrades
GorillaTrades Apr. 10 at 7:37 PM
Top 3 #momentum #stocks In The GorillaTrades #portfolio This Week: Stoke Therapeutics $STOK +6.7%, Celcuity $CELC +3.6%, and Cincinnati Financial $CINF +2.5%
0 · Reply
Doozio
Doozio Apr. 10 at 1:05 AM
$IWM $SMH $XBI how long until they go from fear to walking ENTA da weekend chasing $STTK s and $STOK s.
0 · Reply
NorthStarStats
NorthStarStats Apr. 8 at 8:39 PM
Output from a custom NorthStarStats momentum scanner highlighting stocks with strengthening price structure and momentum. Setups to watch and study — not trade recommendations. $FRT Score 100, $ANET Score 98, $ENTG Score 98, $STOK Score 98, $ASND Score 98
0 · Reply
Doozio
Doozio Mar. 31 at 2:01 PM
$XBI list of biotech $STOK s that $AUPH to $ASND after this 🐑 correction.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 26 at 7:00 PM
$STOK Q4 '25 Earnings Results & Recap Stoke Therapeutics expects its cash, cash equivalents, and marketable securities of approximately $390.9M as of December 31, 2025, will fund operations into 2028, and anticipates pivotal Phase 3 data for zorevunersen in mid-2027.
0 · Reply
ObeCalp
ObeCalp Mar. 26 at 5:59 PM
$STOK Of course, I buy when green... and shortly after it goes red. Yay, me.
0 · Reply
Quantumup
Quantumup Mar. 20 at 11:53 AM
Canaccord Genuity⬆️ $STOK's PT to $60 from $36 and reiterated at a Buy rating. $BIIB $PRAX DRUG UCBJY JAZZ HLUBF HLBBF Here's what Canaccord Genuity had to say in its note to investors: https://x.com/Quantumup1/status/2034960529656029691?s=20
0 · Reply
danaos
danaos Mar. 19 at 1:04 AM
$STOK Price Target $25 (shortterm)
0 · Reply
LadsAndGents
LadsAndGents Mar. 9 at 2:21 PM
$STOK why don’t just buy this out
0 · Reply
janed102
janed102 Mar. 5 at 8:24 AM
$STOK https://www.nejm.org/doi/full/10.1056/NEJMoa2506295
0 · Reply
janed102
janed102 Mar. 5 at 8:22 AM
$STOK https://www.bbc.co.uk/news/articles/c3rzj9jy9e8o
0 · Reply
MK724
MK724 Mar. 2 at 5:09 PM
$STOK what’s the next resistance?
0 · Reply